Proceedings of the National Academy of SciencesMicrobiologyPeer-reviewed journal article
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
Adam A. CapoferriiD, Ann P. Wiegand, Feiyu F. Hong, Jana L. JacobsiD, Jonathan Spindler, Andrew MusickiD, Michael J. BaleiD, Wei ShaoiD, Michele D. Sobolewski, Anthony Richard CilloiD, Brian T. LukeiD, Christine M. FennesseyiD, Robert J. GorelickiD, Rebecca HohiD, Elias Konstantine HalvasiD, Steven G. DeeksiD, John M. CoffiniD, John W. MellorsiD, Mary F. KearneyiD
Abstract
In the absence of antiretroviral therapy (ART), a subset of individuals, termed HIV controllers, have levels of plasma viremia that are orders of magnitude lower than non-controllers who are at higher risk for HIV disease progression. In addition to having fewer infected cells resulting in fewer cells with HIV RNA, it is possible that lower levels of plasma viremia in controllers is due to a lower fraction of the infected cells having HIV-1 unspliced RNA (HIV usRNA) compared with non-controllers. To directly test this possibility, we used sensitive and quantitative single cell sequencing methods to compare the fraction of infected cells that contain one or more copies of HIV usRNA in peripheral blood mononuclear cells (PBMC) obtained from controllers and non-controllers. The fraction of infected cells containing HIV usRNA did not differ between the two groups. Rather, the levels of viremia were strongly associated with the total number of infected cells that had HIV usRNA, as reported by others, with controllers having 34-fold fewer infected cells per million PBMC. These results reveal for the first time that viremic control is not associated with a lower fraction of proviruses expressing HIV usRNA, unlike what is reported for elite controllers, but is only related to having fewer infected cells overall, maybe reflecting greater immune clearance of infected cells. Our findings show that proviral silencing is not a key mechanism for viremic control and will help to refine strategies towards achieving HIV remission without ART.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 7
- FWCI
- 1.08
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIV-1 controllers possess a unique CD8+ T-cell activation phenotype and loss of control is associated with increased expression of exhaustion markers
A. D. Jones, Z. Capriotti, … Z. KLASE·bioRxiv·Apr 9, 2024
- A role for CD4 helper cells in HIV control and progression
I. M. Rouzine·bioRxiv·Dec 20, 2021
- ICER controls HIV-1 infection and replication in elite controllers
- HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus
Elias Konstantine Halvas, Kevin W. Joseph, … John W. Mellors·Journal of Clinical InvestigationPeer-reviewed·Oct 4, 2020
- Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection
Ashok K. Dwivedi, David A. Siegel, … Sulggi A. Lee·bioRxiv·Jan 10, 2023
- Selective infection and loss of PRDM1+ LN Tfh cells in uncontrolled HIV infection precludes formation of Tfh reservoirs under ART
Vincent H. Wu, Jayme M.L. Nordin, … Michael R. Betts·bioRxiv·Dec 15, 2025